PURPOSE: To assess the contribution of the advanced breast cancer (ABC) multidisciplinary team meetings (MDMs) to patient care and clinical outcomes. METHODS: Members of ABC MDMs at two health services completed questionnaires in November 2007. The questionnaire asked about the performance of the MDMs and their contribution to improvement in patient care in five domains: medical management, psychosocial care, palliative care, care in the community, and benefits for team members. A final section covered the perceived value and importance of the MDM in patient management. Descriptive statistics (frequencies, mean, and standard deviation) were used to summarize the performance, improvement, and importance scores. RESULTS: A total of 27 multidisciplinary team members (73%) completed the questionnaire. The MDM performed best in medical management (mean performance score out of 5 [M] = 3.78) and palliative care (M = 3.77). These were also the areas that were most improved through the MDM. Benefits to team members and care in the community (both M = 3.05) ranked lowest by both measures. The MDM provided the most benefit for patient management in the areas of "awareness of services available" (M = 4.32), "efficiency of referrals" (M = 4.27) and "supportive care for patients" (M = 4.27). "Awareness of services available," "psychological care for patients," and "continuity of care" were considered the most important (M = 4.64). CONCLUSION: The study provides evidence that MDMs make an important contribution to the logistical and medical management of patients with advanced breast cancer.
PURPOSE: To assess the contribution of the advanced breast cancer (ABC) multidisciplinary team meetings (MDMs) to patient care and clinical outcomes. METHODS: Members of ABC MDMs at two health services completed questionnaires in November 2007. The questionnaire asked about the performance of the MDMs and their contribution to improvement in patient care in five domains: medical management, psychosocial care, palliative care, care in the community, and benefits for team members. A final section covered the perceived value and importance of the MDM in patient management. Descriptive statistics (frequencies, mean, and standard deviation) were used to summarize the performance, improvement, and importance scores. RESULTS: A total of 27 multidisciplinary team members (73%) completed the questionnaire. The MDM performed best in medical management (mean performance score out of 5 [M] = 3.78) and palliative care (M = 3.77). These were also the areas that were most improved through the MDM. Benefits to team members and care in the community (both M = 3.05) ranked lowest by both measures. The MDM provided the most benefit for patient management in the areas of "awareness of services available" (M = 4.32), "efficiency of referrals" (M = 4.27) and "supportive care for patients" (M = 4.27). "Awareness of services available," "psychological care for patients," and "continuity of care" were considered the most important (M = 4.64). CONCLUSION: The study provides evidence that MDMs make an important contribution to the logistical and medical management of patients with advanced breast cancer.
Authors: Marije Bosch; Marjan J Faber; Juliette Cruijsberg; Gerlienke E Voerman; Sheila Leatherman; Richard P T M Grol; Marlies Hulscher; Michel Wensing Journal: Med Care Res Rev Date: 2009-08-19 Impact factor: 3.929
Authors: James D Harrison; Ellis T Choy; Andrew Spillane; Phyllis Butow; Jane M Young; Alison Evans Journal: Breast Date: 2008-05-01 Impact factor: 4.380
Authors: J H Chang; E Vines; H Bertsch; D L Fraker; B J Czerniecki; E F Rosato; T Lawton; E F Conant; S G Orel; L Schuchter; K R Fox; N Zieber; J H Glick; L J Solin Journal: Cancer Date: 2001-04-01 Impact factor: 6.860
Authors: Eberechukwu Onukwugha; Nicholas J Petrelli; Kathleen M Castro; James F Gardner; Jinani Jayasekera; Olga Goloubeva; Ming T Tan; Erica J McNamara; Howard A Zaren; Thomas Asfeldt; James D Bearden; Andrew L Salner; Mark J Krasna; Irene Prabhu Das; Steve B Clauser; Eberechukwu Onukwugha; Nicholas J Petrelli; Kathleen M Castro; James F Gardner; Jinani Jayasekera; Olga Goloubeva; Ming T Tan; Erica J McNamara; Howard A Zaren; Thomas Asfeldt; James D Bearden; Andrew L Salner; Mark J Krasna; Irene Prabhu Das; Steve B Clauser Journal: J Oncol Pract Date: 2015-10-13 Impact factor: 3.840
Authors: Sarah A Wall; Erin Stevens; Jennifer Vaughn; Naresh Bumma; Ashley E Rosko; Uma Borate Journal: Curr Hematol Malig Rep Date: 2022-01-13 Impact factor: 4.213